PR TIMES (3922) Q4 2025 earnings summary

Executive summary

• FY2024 marked an 18th consecutive year of revenue growth and profitability; net sales rose 17.1% to ¥8,003.4m and operating profit rose 7.5% to ¥1,877.3m, both record highs.

• PR TIMES usage expanded to 108,605 customer companies, including 61.5% of listed Japanese companies; Jooto and Tayori also grew paying users and average prices.

Financial highlights

• FY2024 gross profit was ¥6,721.9m, EBITDA ¥2,174.3m and ordinary profit ¥1,873.3m; parent-attributable profit was ¥1,118.9m, down 3.7% YoY.

• Gross margin was 84.0%, down from 86.2%; operating margin was 23.5%, down from 25.5%.

• Q4 net sales were ¥2,018m, up 12.5% YoY and down 3.6% QoQ; operating profit was ¥280m, up 21.3% YoY and down 56.1% QoQ.

• Q4 EBITDA was ¥416m, up 42.7% YoY; profit was ¥110m, down 31.3% YoY, reflecting impairment charges.

• Results were within forecast ranges despite ¥72m of unplanned share-based payment expense and upfront advertising and R&D spending.

Outlook and guidance

• FY2025 forecast: net sales ¥9,205m (+15.0%), operating profit ¥3,149m (+67.7%), EBITDA ¥3,442m (+58.3%) and parent-attributable profit ¥2,122m (+89.7%).

• FY2025 year-end dividend forecast is ¥13.20 per share; policy is progressive dividends based on DOE of at least 2%.

• Priorities include at least 10% press-release growth, rebuilding PR partner services and web clipping, and increasing sales per large-company customer.

• Jooto and Tayori target 60% sales growth and their first operating profit; glucose targets external sales growth and NAVICUS its first profitable year in five fiscal years.

• FY2025 is a transition year toward FY2030 goals; the ¥3.5bn Milestone 2025 operating-profit target is ambitious and currently diverges from projections.